OCGN Ocugen, Inc. Stock Quote

OCGN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	0.50%	Shs Outstand	188.17M	Perf Week	-14.09%
Market Cap	1.70B	Forward P/E	2.07	EPS next Y	3.98	Insider Trans	-42.68%	Shs Float	182.53M	Perf Month	19.28%
Income	-34.40M	PEG	-	EPS next Q	0.38	Inst Own	7.60%	Short Float	20.29%	Perf Quarter	-25.11%
Sales	0.04M	P/S	39910.28	EPS this Y	79.00%	Inst Trans	3.23%	Short Ratio	0.57	Perf Half Y	2572.08%
Book/sh	0.13	P/B	63.31	EPS next Y	81.09%	ROA	-86.70%	Target Price	9.00	Perf Year	2531.07%
Cash/sh	0.12	P/C	70.87	EPS next 5Y	-	ROE	-125.70%	52W Range	0.17 - 18.77	Perf YTD	349.73%
Dividend	-	P/FCF	-	EPS past 5Y	70.80%	ROI	-	52W High	-56.15%	Beta	4.51
Dividend %	-	Quick Ratio	7.20	Sales past 5Y	-	Gross Margin	-	52W Low	4741.18%	ATR	1.80
Employees	15	Current Ratio	7.20	Sales Q/Q	-	Oper. Margin	-	RSI (14)	44.98	Volatility	21.32% 20.25%
Optionable	Yes	Debt/Eq	0.09	EPS Q/Q	-106.80%	Profit Margin	-	Rel Volume	0.82	Prev Close	8.61
Shortable	Yes	LT Debt/Eq	0.08	Earnings	May 07 BMO	Payout	-	Avg Volume	65.01M	Price	8.23
Recom	2.20	SMA20	-15.22%	SMA50	-5.05%	SMA200	131.50%	Volume	53,110,355	Change	-4.41%

May-07-21

Downgrade

Cantor Fitzgerald

Overweight → Neutral

Feb-09-21

Downgrade

Chardan Capital Markets

Buy → Neutral

$0.70 → $13

Feb-04-21

Upgrade

H.C. Wainwright

Neutral → Buy

$4.50

May-13-21 06:30AM	Can Ocugen Overcome This Major Hurdle? Motley Fool
May-12-21 08:38AM	Is the Options Market Predicting a Spike in Ocugen (OCGN) Stock? Zacks -13.03%
May-11-21 06:38AM	Could Ocugen Be a Millionaire Maker Stock? Motley Fool
May-10-21 03:42PM	Ocugens Valuation Deserves a Haircut, Says Analyst TipRanks +10.72%
May-08-21 06:06AM	3 Investments That Turned $35,000 Into $1 Million (or More) in Just 6 Months Motley Fool
May-07-21 10:01PM	Ocugen, Inc. (OCGN) Q1 2021 Earnings Call Transcript Motley Fool
12:24PM	OCGN Stock: Why Red-Hot Ocugen Is Plunging Again Today InvestorPlace
11:40AM	Why Ocugen Stock Is Tanking Today Motley Fool
10:44AM	Ocugen (OCGN) Miss Earnings & Revenues Estimates in Q1 Zacks
10:37AM	Ocugen Stock Has a Big Pullback Coming, and That Will Be Your Chance InvestorPlace
10:07AM	Ocugen Stock Is a Risky Proposition Despite Its High Valuation InvestorPlace
07:30AM	Ocugen Provides Business Update and First Quarter 2021 Financial Results GlobeNewswire
06:45AM	Ocugen Inc to Host Earnings Call ACCESSWIRE
06:15AM	Does Ocugen Have a Real Shot at the U.S. COVID Vaccine Market? Motley Fool
06:10AM	Better Vaccine Stock: Ocugen or Vaxart? Motley Fool
May-06-21 12:32PM	BioCryst Shares Trading Higher As Q1 Sales Beat Was Supported By Orladeyo Revenues Benzinga -12.19%
12:28PM	Ocugen Shares Sink Despite OCU200 Being Comparable To Aflibercept In Reducing Neovascularization, Damage To Retina In Animal Study Benzinga
09:05AM	Drug/Biotech Stock Q1 Earnings on May 7: RDUS, CRON & OCGN Zacks
07:30AM	Ocugen Presents New Preclinical OCU200 Data at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting GlobeNewswire
May-05-21 06:30AM	Can This News Push Ocugen Ahead of Pfizer and Moderna? Motley Fool -12.79%
May-04-21 07:53PM	Why Zomedica, Naked Brand, Ocugen, and Other Reddit Stocks Crashed Today Motley Fool -20.22%
06:03AM	2 Expensive Stocks I'd Definitely Avoid Motley Fool
May-03-21 06:36PM	Here's Why Ocugen Stock Soared Today Motley Fool +23.76%
04:35PM	Ocugen to Host Conference Call on Friday, May 7 at 8:30 a.m. ET to Discuss First Quarter 2021 Financial Results and Provide Business Update GlobeNewswire
10:51AM	Ocugen's stock is up after sharing preprint about COVID-19 vaccine effectiveness against lesser known Brazilian variant MarketWatch
10:48AM	Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards? Zacks
08:07AM	Ocugen Shares Gain After Its Partner's COVID-19 Vaccine Shows Effectiveness Against Multiple Variants Benzinga
07:30AM	Ocugen announces studies showing COVAXIN potentially effective against three key variants of SARS-CoV-2 GlobeNewswire
06:50AM	Ocugen Soars as Vaccine Shows Potential With COVID-19 Variants TheStreet.com
Apr-30-21 06:04AM	Better Robinhood Stock: Ocugen or Aphria? Motley Fool +5.94%
Apr-28-21 08:00AM	Ocugen Inc. Announces Closing of $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market GlobeNewswire
06:01AM	Here's the Biggest Risk With Buying Ocugen Stock Right Now Motley Fool
Apr-27-21 07:00AM	Is Ocugen a Buy? Motley Fool
04:33AM	Are Investors Undervaluing Ocugen, Inc. (NASDAQ:OCGN) By 48%? Simply Wall St.
Apr-26-21 07:18PM	Why Ocugen, Zomedica, Naked Brand, and Other Reddit Stocks Soared Today Motley Fool +20.35%
11:55AM	Ocugen Announces $100M Direct Offering; Shares Soar 15.6% SmarterAnalyst
Apr-25-21 06:06AM	3 Stocks That Turned $250,000 Into $1 Million (or More) Since the Year Began Motley Fool
Apr-23-21 09:06PM	Here's Why Ocugen Stock Rocketed 47% Today -- and Then Gave Up Almost All Its Gains Motley Fool
03:00PM	Ocugen Inc. Announces $100 Million Registered Direct Offering of Common Stock Priced at a Premium to Market GlobeNewswire
02:45PM	Ocugen Looks Less Interesting With Each Passing Shot InvestorPlace
11:23AM	Ocugen Stock Relief Pop Is Great, But It Needs More InvestorPlace
06:15AM	Is It Too Late to Buy Ocugen Stock? Motley Fool
Apr-22-21 05:25PM	Here's Why Ocugen Stock Skyrocketed Today Motley Fool +42.92%
01:35PM	Why Ocugen and Nikola Are Powering the Nasdaq Higher Motley Fool
12:45PM	Theres an Opportunity Brewing in Ocugen Stock, Says Analyst TipRanks
10:37AM	Ocugen (OCGN) Up on Positive Data for COVID-19 Vaccine Candidate Zacks
08:39AM	Ocugen Partner Reports Strong Phase 3 Results for Coronavirus Vaccine Motley Fool
06:54AM	Could This Little-Known Company's Vaccine Candidate Leapfrog Moderna and Pfizer? Motley Fool
Apr-21-21 03:41PM	Why Ocugen Stock Surged Today Motley Fool +17.75%
08:19AM	Ocugens COVID-19 Vaccine Co-Development Partner, Bharat Biotech, Shares Second Interim Results demonstrating 100% Protection against Severe Disease including Hospitalization GlobeNewswire
Apr-20-21 06:25AM	Reddit Traders Can't Get Enough of These 2 Resurgent Biotech Stocks Motley Fool
Apr-16-21 01:52PM	7 Reddit Penny Stocks to Buy for a Biotech Boom InvestorPlace -6.02%
Apr-15-21 06:01AM	3 Robinhood Stocks That Have More Than Doubled in 2021: Are They Buys Now? Motley Fool -10.87%
Apr-14-21 08:00AM	Ocugen Inc. Announces John Paul Gabriel as Senior Vice President, Manufacturing and Supply Chain GlobeNewswire
Apr-10-21 06:06AM	5 Stocks That Made People Millionaires in 6 Months Motley Fool
Apr-07-21 05:58AM	Ocugen's Charts Suggest We Look for a Better Buying Opportunity TheStreet.com +8.50%
Apr-05-21 08:30AM	Are Options Traders Betting on a Big Move in Ocugen (OCGN) Stock? Zacks
Apr-04-21 07:23AM	Should You Buy Ocugen in April? Motley Fool
Apr-01-21 05:50PM	Ocugen (OCGN) Stock Sinks As Market Gains: What You Should Know Zacks
Mar-29-21 08:54AM	Ocugen Inc. to Participate in a Cantor Fitzgerald Fireside Chat to Discuss COVAXIN COVID-19 Vaccine Development GlobeNewswire -8.84%
Mar-26-21 11:53AM	Is Approval Even Enough for Ocugen Stock? InvestorPlace -7.40%
Mar-25-21 10:00AM	Why Is Everyone Talking About Ocugen Stock? Motley Fool
Mar-23-21 07:31AM	3 Top Value Stocks to Buy Now Motley Fool -5.28%
Mar-22-21 01:15PM	Ocugen: Potential Covid-19 Vaccine EUA Warrants a Buy, Says Analyst TipRanks
Mar-21-21 01:00PM	Here's Why Clinical-Stage Biotechs Get Hit Harder During a Market Decline Motley Fool
Mar-18-21 09:30PM	Ocugen, Inc. (OCGN) Q4 2020 Earnings Call Transcript Motley Fool -6.81%
06:02PM	Top Biotech Stocks for Q2 2021 Investopedia
01:00PM	What Really Mattered With Ocugen's Q4 Update Motley Fool
07:30AM	Ocugen Provides Business Update and Full Year 2020 Financial Results GlobeNewswire
06:30AM	Ocugen Inc to Host Earnings Call ACCESSWIRE
06:16AM	3 Biotech Stocks to Avoid Right Now Motley Fool
Mar-16-21 07:48AM	Ocugen Plans To Sell 100M Covaxin Doses In US This Year: Reuters Benzinga -7.78%
Mar-15-21 06:28PM	UPDATE 1-Ocugen seeks to sell 100 mln Indian vaccine doses in U.S. in 2021 Reuters
05:45PM	Ocugen (OCGN) Stock Sinks As Market Gains: What You Should Know Zacks
06:00AM	Could These 3 Stocks Be 10-Baggers in 2021? Motley Fool
Mar-13-21 06:00AM	Should You Buy These Vaccine Stocks After the Sell-Off? Motley Fool
Mar-12-21 05:45PM	Ocugen to Host Conference Call on Thursday, March 18 at 8:30 a.m. ET to Discuss 2020 Financial Results and Provide a Business Update GlobeNewswire
12:32PM	Ocugen Stock May Have One More Rally in It Before Its Over InvestorPlace
Mar-08-21 05:45PM	Ocugen (OCGN) Dips More Than Broader Markets: What You Should Know Zacks
02:50PM	Ocugen Inc. to Present at Upcoming March Investor Conferences GlobeNewswire
10:12AM	Should You Buy Ocugen Stock in March? Motley Fool
Mar-07-21 08:00AM	Here's the Biggest Problem Ocugen Faces Right Now Motley Fool
08:00AM	Does Hopeful Vaccine Data Make Ocugen a Buy? Motley Fool
Mar-06-21 06:04AM	Better Reddit Stock: Ocugen vs. Zomedica Motley Fool
Mar-03-21 05:03PM	Why Ocugen Stock Surged Today Motley Fool +8.96%
12:33PM	Is Ocugen Stock a Buy Right Now? This Is What You Need to Know TipRanks
11:51AM	Why Ocugen and UWM Soared While the Stock Markets Went Nowhere Motley Fool
08:20AM	Ocugen stock soars after partner Bharat Biotech COVID-19 vaccine candidate shows 81% efficacy MarketWatch
08:00AM	Ocugens COVID-19 Vaccine Co-Development Partner, Bharat Biotech shares Phase 3 Interim Results of COVAXIN, Demonstrates Efficacy of 81% GlobeNewswire
07:20AM	Ocugen Shares Are Trading Higher On Its Partner's COVID-19 Vaccine Candidate Showing 81% Efficacy Benzinga
05:12AM	Ocugen Jumps After Vaccine Candidate Found 81% Effective TheStreet.com
Feb-26-21 06:57AM	Should You Buy Ocugen for Its COVID Vaccine? Motley Fool +36.87%
Feb-24-21 06:09AM	1 Big Problem Ocugen Could Face That Investors Might Be Overlooking Motley Fool
Feb-23-21 07:30AM	European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis GlobeNewswire -6.43%
Feb-20-21 10:00AM	Beware: Ocugen Is a Near $2 Billion Company That Has No Revenue InvestorPlace
Feb-19-21 06:01AM	Forget Ocugen! Here's a COVID Stock That Could Make You Richer Quicker Motley Fool
Feb-18-21 06:15AM	Better Buy: Ocugen vs. Zomedica Motley Fool
06:04AM	Should You Buy Ocugen Stock? Motley Fool
Feb-17-21 06:25AM	2 High-Growth Robinhood Stocks That Could Realistically Triple Your Money in 2021 Motley Fool -6.66%
Feb-16-21 12:38PM	Why Ocugen Stock Is Jumping Today Motley Fool +6.61%

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tammara Vijay	Senior Vice President	May 04	Option Exercise	0.81	15,711	12,755	6,500	May 05 08:15 PM
Tammara Vijay	Senior Vice President	May 04	Sale	13.68	15,711	214,954	0	May 05 08:15 PM
Musunuri Shankar	Chief Executive Officer	May 03	Option Exercise	0.51	195,809	99,863	601,809	May 03 09:00 PM
Tammara Vijay	Senior Vice President	May 03	Option Exercise	0.46	4,317	1,986	4,317	May 03 08:53 PM
Kompella Uday	Director	May 03	Sale	15.01	50,000	750,500	550,674	May 03 09:05 PM
Musunuri Shankar	Chief Executive Officer	May 03	Sale	14.24	195,809	2,788,320	406,000	May 03 09:00 PM
Potti Manish	Director	May 03	Sale	15.02	60,000	901,200	63,429	May 05 08:13 PM
Potti Manish	Director	May 03	Sale	15.01	28,000	420,280	0	May 05 08:13 PM
Tammara Vijay	Senior Vice President	May 03	Sale	16.00	4,317	69,072	0	May 03 08:53 PM
Kompella Uday	Director	Apr 30	Option Exercise	0.51	20,000	10,200	620,674	May 03 09:05 PM
Kompella Uday	Director	Apr 30	Sale	11.56	20,000	231,200	600,674	May 03 09:05 PM
Tammara Vijay	Senior Vice President	Apr 29	Option Exercise	0.75	29,991	22,442	12,880	May 03 08:53 PM
Subramanian Sanjay	Chief Financial Officer	Apr 29	Option Exercise	2.19	7,990	17,498	53,581	May 03 09:06 PM
Subramanian Sanjay	Chief Financial Officer	Apr 29	Sale	10.98	7,990	87,730	45,591	May 03 09:06 PM
Tammara Vijay	Senior Vice President	Apr 29	Sale	10.97	29,991	328,881	0	May 03 08:53 PM
Kompella Uday	Director	Apr 26	Sale	11.70	350,000	4,095,000	600,674	Apr 28 06:52 PM
Kumar Ramesh	Director	Apr 19	Option Exercise	0.51	7,500	3,825	7,500	Apr 21 04:16 PM
Kumar Ramesh	Director	Apr 19	Sale	5.33	7,500	39,975	0	Apr 21 04:16 PM
Potti Manish	Director	Mar 05	Option Exercise	0.84	28,000	23,520	28,000	Mar 08 08:38 PM
Subramanian Sanjay	Chief Financial Officer	Jan 29	Option Exercise	0.51	35,591	18,151	45,591	Feb 01 05:31 PM
Castillo Kirsten	Director	May 28	Buy	0.31	75,000	23,498	75,000	May 29 06:48 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience